Integra LifeSciences IART Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$516.47M— | —— | $67.74M-62.5% | $180.55M+6.8% | ||
| $151.83M+7.8% | $140.89M+14.1% | $123.51M+4.4% | $118.3M-1.3% | ||
| $18.58M-23.8% | $24.38M+21.0% | $20.14M-27.3% | $27.73M-23.4% | ||
| $50.38M-61.1% | $129.38M-7.6% | $139.96M-47.1% | $264.47M-15.4% | ||
| $81.44M-22.0% | $104.42M+56.2% | $66.87M+57.9% | $42.34M-11.8% | ||
| -$108.06M+72.3% | -$390.81M-315% | -$94.18M— | —— | ||
| —— | —— | -$229.93M+8.7% | -$251.95M— | ||
| —— | —— | —— | —— |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Integra LifeSciences generate?
- Integra LifeSciences (IART) generated $71.4M in operating cash flow over the trailing twelve months.
- What is Integra LifeSciences's free cash flow?
- After $67.4M of capital expenditures, Integra LifeSciences's free cash flow was -$61.8M over the trailing twelve months, down 193.2% year over year.
- Where does Integra LifeSciences's cash flow data come from?
- Every line is extracted from Integra LifeSciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
